Merck accesses bioprinted testing tissues; Accenture adds Oracle tools to R&D cloud;

> Merck ($MRK) signed up to use Organovo's bioprinted human tissue toxicology model. Article

> Accenture built Oracle's data management tools into cloud R&D offering, weeks after it tightened its ties to Medidata. Release

> Illumina ($ILMN) wrapped up another big quarter, in which it grew sales by 28% year on year. Results

> BioClinica named former Oracle executive Mukhtar Ahmed as its eClinical president. News

> Desktop Genetics introduced a gene editing software platform. Item

> Genedata unveiled software to support the profiling of patients and compounds. Post

> Medidata reported strong first quarter results, in which it added a record number of new clients. More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.